June 1, 2021
The US Food and Drug Administration (FDA) has approved a once-daily oral medication, which is a combination of olanzapine and samidorphan (Lybalvi, Alkermes), for the treatment […]
May 28, 2021
The first drug to target KRAS mutations in non-small cell lung cancer (NSCLC) has been approved by the US Food and Drug Administration. KRAS mutations are […]
May 28, 2021
The US Food and Drug Administration (FDA) has expanded the indication for rimegepant (Nurtec ODT, Biohaven) to include prevention of migraine in adults. Last year, rimegepant […]
May 28, 2021
The US Food and Drug Administration (FDA) has approved ozanimod (Zeposia) for adults with moderately to severely active ulcerative colitis (UC), the company has announced. Ozanimod […]
May 25, 2021
The immunotherapy cemiplimab (Libtayo) looks set to have two further cancer indications in Europe: nonsmall cell lung cancer (NSCLC) and basal cell carcinoma (BCC). The European […]
May 21, 2021
Boston Scientific Corporation has recalled its VICI SDS and VICI RDS venous stent systems in response to reports that the stents may migrate or move from […]
May 21, 2021
The US Food and Drug Administration (FDA) today granted an accelerated approval for amivantamab (Rybrevant) as the first targeted treatment for patients with non–small cell lung […]
May 20, 2021
The US Food and Drug Administration has approved the adjuvant use of nivolumab (Opdivo) in patients with resected esophageal or gastroesophageal junction cancer who have received […]
May 19, 2021
A rare, life-threatening anemia now has a new treatment option. The Food and Drug Administration announced the approval of pegcetacoplan (Empaveli) injection to treat adults with […]